These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33309753)

  • 1. Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase.
    Flydal MI; Kråkenes TA; Tai MDS; Tran MPA; Teigen K; Martinez A
    Biochimie; 2021 Apr; 183():126-132. PubMed ID: 33309753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pharmacological chaperones on brain tyrosine hydroxylase and tryptophan hydroxylase 2.
    Calvo AC; Scherer T; Pey AL; Ying M; Winge I; McKinney J; Haavik J; Thöny B; Martinez A
    J Neurochem; 2010 Aug; 114(3):853-63. PubMed ID: 20492352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopa-responsive dystonia caused by tyrosine hydroxylase deficiency: Three cases report and literature review.
    Dong HY; Feng JY; Yue XJ; Shan L; Jia FY
    Medicine (Baltimore); 2020 Aug; 99(33):e21753. PubMed ID: 32872068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobiopterin (BH
    Jung-Kc K; Tristán-Noguero A; Altankhuyag A; Piñol Belenguer D; Prestegård KS; Fernandez-Carasa I; Colini Baldeschi A; Sigatulina Bondarenko M; García-Cazorla A; Consiglio A; Martinez A
    J Inherit Metab Dis; 2024 May; 47(3):494-508. PubMed ID: 38196161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms.
    Hole M; Underhaug J; Diez H; Ying M; Røhr ÅK; Jorge-Finnigan A; Fernàndez-Castillo N; García-Cazorla A; Andersson KK; Teigen K; Martinez A
    Biochim Biophys Acta; 2015 Sep; 1854(9):1078-89. PubMed ID: 25960279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human tyrosine hydroxylase in Parkinson's disease and in related disorders.
    Nagatsu T; Nakashima A; Ichinose H; Kobayashi K
    J Neural Transm (Vienna); 2019 Apr; 126(4):397-409. PubMed ID: 29995172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia.
    Fossbakk A; Kleppe R; Knappskog PM; Martinez A; Haavik J
    Hum Mutat; 2014 Jul; 35(7):880-90. PubMed ID: 24753243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydrobiopterin shows chaperone activity for tyrosine hydroxylase.
    Thöny B; Calvo AC; Scherer T; Svebak RM; Haavik J; Blau N; Martinez A
    J Neurochem; 2008 Jul; 106(2):672-81. PubMed ID: 18419768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
    Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
    Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quaternary structure of human tyrosine hydroxylase: effects of dystonia-associated missense variants on oligomeric state and enzyme activity.
    Szigetvari PD; Muruganandam G; Kallio JP; Hallin EI; Fossbakk A; Loris R; Kursula I; Møller LB; Knappskog PM; Kursula P; Haavik J
    J Neurochem; 2019 Jan; 148(2):291-306. PubMed ID: 30411798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase variants influence protein expression, cellular localization, stability, enzymatic activity and the physical interaction between tyrosine hydroxylase and GTP cyclohydrolase 1.
    Jung-Klawitter S; Richter P; Yuan Y; Welzel K; Kube M; Bähr S; Leibner A; Flory E; Opladen T
    J Inherit Metab Dis; 2024 May; 47(3):517-532. PubMed ID: 38084654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of a fetal brain affected by a severe form of tyrosine hydroxylase deficiency, a rare cause of early parkinsonism.
    Tristán-Noguero A; Díez H; Jou C; Pineda M; Ormazábal A; Sánchez A; Artuch R; Garcia-Cazorla À
    Metab Brain Dis; 2016 Jun; 31(3):705-9. PubMed ID: 26686676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.
    Nagatsu T; Ichinose H
    Neurochem Res; 1996 Feb; 21(2):245-50. PubMed ID: 9182249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia.
    Kawahata I; Fukunaga K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Chaperones that Protect Tetrahydrobiopterin Dependent Aromatic Amino Acid Hydroxylases Through Different Mechanisms.
    Hole M; Jorge-Finnigan A; Underhaug J; Teigen K; Martinez A
    Curr Drug Targets; 2016; 17(13):1515-26. PubMed ID: 26953246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.
    Tabrez S; Jabir NR; Shakil S; Greig NH; Alam Q; Abuzenadah AM; Damanhouri GA; Kamal MA
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):395-409. PubMed ID: 22483313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.
    Clot F; Grabli D; Cazeneuve C; Roze E; Castelnau P; Chabrol B; Landrieu P; Nguyen K; Ponsot G; Abada M; Doummar D; Damier P; Gil R; Thobois S; Ward AJ; Hutchinson M; Toutain A; Picard F; Camuzat A; Fedirko E; Sân C; Bouteiller D; LeGuern E; Durr A; Vidailhet M; Brice A;
    Brain; 2009 Jul; 132(Pt 7):1753-63. PubMed ID: 19491146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.
    Kawahata I; Ohtaku S; Tomioka Y; Ichinose H; Yamakuni T
    Biochem Biophys Res Commun; 2015 Sep; 465(1):53-8. PubMed ID: 26225746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.